Denali Therapeutics: Of The Form 8k Filed By Denali Therapeutics Inc. (the “company”) On December 4, 2025 Related To The Synthetic Royalty Funding Agreement Between The Company And Royalty Pharma (the “royalty Agreement”), And The Information Contained In Item 7.01 Below, Is Hereby Incorporated By Reference Into This Item 2.03 In Its Entirety, Regulation Fd Disclosure

Show full article

This functionality is available for registred users only

• Full name
  Denali Therapeutics Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***